Clinical Trial Update: A Study on Bioequivalence of Cabergoline Tablets in Human Body [Phase 1]

View source ↗

Summary

A Phase 1 bioequivalence study of cabergoline tablets for hyperprolactinemia is being conducted, sponsored by Changchun GeneScience Pharmaceutical Co., Ltd.; th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperprolactinemia

Drugs mentioned

• CABERGOLINE (CABERGOLINE)

Snippet

Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. | Conditions: Hyperprolactinemia | Phase 1 | Status: ACTIVE_NOT_RECRUITING